Table 5.

Frequency of anopheline (all species) sporozoite infection status for both spatial repellent (SR) and placebo treatment arms

Treatment allocation	Plasmodium falciparum	Plasmodium vivax.	Indeterminate*	Noninfected	Sporozoite positivity rate†
Baseline
SR	12	9	0	4,706	0.4%
Placebo	12	9	0	6,244	0.3%
Intervention
SR	3	8	0	8,130	0.1%
Placebo	6	1	1	9,615	0.1%

SR = spatial repellent.

^*Indeterminate defined as Plasmodium-positive sample but parasite species not identifiable.

^†Sporozoite positivity rate = [(Pf + Pv)/(Pf + Pv + indeterminate + noninfected)] x 100%.